Llwytho...
The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma
No effective systemic treatment is available for patients with unresectable, recurrent, or metastatic mucoepidermoid carcinoma (MEC), the most common salivary gland malignancy. MEC is frequently associated with a t(11;19)(q14-21;p12-13) translocation that creates a CRTC1-MAML2 fusion gene. The CRTC1...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | JCI Insight |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Society for Clinical Investigation
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8119194/ https://ncbi.nlm.nih.gov/pubmed/33830080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.139497 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|